Cannell & Spears’s Nu Skin NUS Stock Holding History

Cannell & Spears’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,692	Closed	-$266K	–	248
2021 Q2	$266K	Buy	+4,692	New	+$267K	0.02%	209

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cannell & Spears's NUS Position: Q3 2021 in Review

Cannell & Spears sold out of Nu Skin (NUS) in Q3 2021, closing a stake of 4,692 shares — an estimated $266K sold.

Cannell & Spears first reported a position in NUS in Q2 2021 and held it in 1 quarter. The position peaked at $266K in Q2 2021. 246 funds tracked by Wall St. Rank hold NUS as of Q3 2021.

Cannell & Spears reported no remaining Nu Skin position as of Q3 2021 after selling out during the quarter.
Cannell & Spears sold 4,692 Nu Skin shares in Q3 2021, an estimated $266K.
Cannell & Spears first reported a position in Nu Skin in Q2 2021 and held it in 1 quarter.
Cannell & Spears's Nu Skin position peaked at $266K in Q2 2021.
246 funds tracked by Wall St. Rank held Nu Skin as of Q3 2021.

Based on Cannell & Spears's 13F filing for Q3 2021, filed 15 Nov 2021.